Valeant’s Drug Price Strategy Enriches It, but Infuriates Patients and Lawmakers

By ANDREW POLLACK and SABRINA TAVERNISE from NYT Business Day http://www.nytimes.com/2015/10/05/business/valeants-drug-price-strategy-enriches-it-but-infuriates-patients-and-lawmakers.html
via IFTTT